DOI QR코드

DOI QR Code

Socioeconomic Impact of Cancer in Member Countries of the Association of Southeast Asian Nations (ASEAN): the ACTION Study Protocol

  • Published : 2012.02.29

Abstract

Cancer can be a major cause of poverty. This may be due either to the costs of treating and managing the illness as well as its impact upon people's ability to work. This is a concern that particularly affects countries that lack comprehensive social health insurance systems and other types of social safety nets. The ACTION study is a longitudinal cohort study of 10,000 hospital patients with a first time diagnosis of cancer. It aims to assess the impact of cancer on the economic circumstances of patients and their households, patients' quality of life, costs of treatment and survival. Patients will be followed throughout the first year after their cancer diagnosis, with interviews conducted at baseline (after diagnosis), three and 12 months. A cross-section of public and private hospitals as well as cancer centers across eight member countries of the Association of Southeast Asian Nations (ASEAN) will invite patients to participate. The primary outcome is incidence of financial catastrophe following treatment for cancer, defined as out-of-pocket health care expenditure at 12 months exceeding 30% of household income. Secondary outcomes include illness induced poverty, quality of life, psychological distress, economic hardship, survival and disease status. The findings can raise awareness of the extent of the cancer problem in South East Asia and its breadth in terms of its implications for households and the communities in which cancer patients live, identify priorities for further research and catalyze political action to put in place effective cancer control policies.

Keywords

References

  1. Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76. https://doi.org/10.1093/jnci/85.5.365
  2. Essue B, Kelly P, Roberts M, et al (2011). We can't afford my chronic illness! The out-of-pocket burden associated with managing chronic obstructive pulmonary disease in western Sydney, Australia. J Health Serv Res Policy, 16, 226-31. https://doi.org/10.1258/jhsrp.2011.010159
  3. EuroQoL Group (1990). EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16, 199-208. https://doi.org/10.1016/0168-8510(90)90421-9
  4. Farmer P, Frenk J, Knaul FM, et al (2010). Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet, 376, 1186-93. https://doi.org/10.1016/S0140-6736(10)61152-X
  5. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer.
  6. Hackett ML, Glozier NS, Martiniuk AL, et al (2011). Sydney epilepsy incidence study to measure illness consequences: the SESIMIC observational epilepsy study protocol. BMC Neurol, 11, 3. https://doi.org/10.1186/1471-2377-11-3
  7. Heeley E, Anderson CS, Huang Y, et al (2009). Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke, 40, 2149-56. https://doi.org/10.1161/STROKEAHA.108.540054
  8. Tongsiri S, Cairns J (2011). Estimating population-based values for EQ-5D Health States in Thailand. Value Health, 14, 1142-5. https://doi.org/10.1016/j.jval.2011.06.005
  9. Tsuchiya A, Ikeda S, Ikegami N, et al (2002). Estimating an EQ-5D population value set: the case of Japan. Health Econ, 11, 341-53. https://doi.org/10.1002/hec.673
  10. Wei JW, Heeley EL, Wang J-G, et al (2010). Comparison of recovery patterns and prognostic indicators for ischemic and hemorrhagic stroke in China. Stroke, 41, 1877-83. https://doi.org/10.1161/STROKEAHA.110.586909
  11. Zigmond AS, Snaith RP (1983). The hospital anxiety and depression scale. Acta Psychiatr Scand, 67, 361-70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

Cited by

  1. The Burden of Cancer in Member Countries of the Association of Southeast Asian Nations (ASEAN) vol.13, pp.2, 2012, https://doi.org/10.7314/APJCP.2012.13.2.411
  2. Costs During the First Five Years Following Cancer Diagnosis in Korea vol.13, pp.8, 2012, https://doi.org/10.7314/APJCP.2012.13.8.3767
  3. Anticancer Activity of Acacia nilotica (L.) Wild. Ex. Delile Subsp. indica Against Dalton's Ascitic Lymphoma Induced Solid and Ascitic Tumor Model vol.13, pp.8, 2012, https://doi.org/10.7314/APJCP.2012.13.8.3989
  4. A mixed method exploration of survivorship among Chinese American and non-Hispanic White breast cancer survivors: the role of socioeconomic well-being vol.22, pp.10, 2013, https://doi.org/10.1007/s11136-013-0374-0
  5. Financial Distress and its Predicting Factors among Iranian Cancer Patients vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1621
  6. The relationship between economic characteristics and health-related quality of life in newly diagnosed cancer patients in Southeast Asia: results from an observational study vol.24, pp.4, 2015, https://doi.org/10.1007/s11136-014-0828-z
  7. Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries vol.15, pp.1, 2017, https://doi.org/10.1186/s12916-016-0768-2
  8. Household Financial Burden and Poverty Impacts of Cancer Treatment in Vietnam vol.2017, pp.2314-6141, 2017, https://doi.org/10.1155/2017/9350147
  9. Health-related quality of life and psychological distress among cancer survivors in a middle-income country vol.27, pp.9, 2018, https://doi.org/10.1002/pon.4787